MAPT and Alzheimer disease: Instead, transgenic models expressing pTau pathology due to overexpression of the human MAPT gene, specifically harboring either a P301S or P301L mutation, do show striking neurodegeneration and often more similarly recapitulate the circadian phenotypes that are seen in AD patients8.